The World of Health & Medicine News

Amazon Pharmacy to launch electronic kiosks for prescriptions at One Medical locations

Amazon Pharmacy to launch electronic kiosks for prescriptions at One Medical locations

Amazon said on Wednesday its pharmacy business in December will begin filling some prescriptions for common medications at electronic kiosks in its One Medical primary care locations, which the company says will reduce barriers to access and limit shipping costs.

Amazon plans to start the offer with One Medical patients in Los Angeles for drugs including antibiotics, asthma inhalers and treatments for high blood pressure, the company said.

The kiosks will be the first in-person pick-up service offered by Amazon Pharmacy, which has been providing prescription services primarily by delivery, said Hannah McClellan Richards, a vice president at Amazon Pharmacy.

One Medical offers a membership structure that allows patients to access primary and urgent care at a subscription fee of $199 annually. Patients without a membership are still able to book an appointment and would be able to use the kiosk, the company said.

Richards said in an interview that the company plans to expand the kiosk model outside of California in 2026 and is in talks with external health systems to introduce the machines through partnerships.

Amazon does not plan to offer medicines that must be refrigerated, such as GLP-1 weight-loss drugs, or more tightly regulated prescriptions like controlled pain medicines through the kiosk.

Inventory for each kiosk will be tailored to the provider, and patients would be able to consult a company pharmacist virtually, Amazon said in a press release.

Amazon.com, the $2.34 trillion e-commerce company, launched pharmaceutical delivery in 2018 through its acquisition of PillPack. In 2023, the company purchased One Medical, a national primary care provider.

Analysts this year have flagged shipping and logistical costs as a potential squeeze on Amazon’s profits.

Chief Financial Officer Brian Olsavsky, in a second-quarter earnings call, said the company planned to make strategic decisions on product placement in an effort to shorten delivery routes and improve availability. “We’re committed to initiatives that further improve our cost structure,” he said at the time.

Richards acknowledged that the most expensive part of the e-commerce supply chain is shipping.

“If you put inventory closer to customers,” she said, “your shipping costs go way down and your demand goes way up.”

spot_img

Explore more

spot_img

US CDC ends guidance that all newborns should get hepatitis B...

US CDC ends guidance that all newborns should get hepatitis B vaccine, in major policy shift The U.S. Centers for Disease Control and Prevention on...

FDA Approves J&J’s Akeega for Expanded Use in Prostate Cancer

FDA Approves J&J's Akeega for Expanded Use in Prostate Cancer Johnson & Johnson JNJ announced that the FDA approved its precision therapy, Akeega (niraparib and abiraterone acetate...

Women are increasingly using steroids — despite these 7 major risks

Women are increasingly using steroids — despite these 7 major risks As fitfluencers push powerlifting, weight training and “whatever it takes” to get toned, more women...

Kyverna’s cell therapy helps patients improve mobility in mid-stage trial

Kyverna's cell therapy helps patients improve mobility in mid-stage trial Kyverna Therapeutics said its experimental cell therapy met the main goal of “significantly” improving patients’...

AstraZeneca, Daiichi’s breast cancer drug gets FDA nod as first-line treatment

AstraZeneca, Daiichi's breast cancer drug gets FDA nod as first-line treatment The U.S. Food and Drug ​Administration has approved ‌Daiichi Sankyo's therapy in combination ‌with...

WHO expert group’s new analysis reaffirms there is no link between...

WHO expert group’s new analysis reaffirms there is no link between vaccines and autism new analysis from a WHO global expert committee on vaccine safety...

US FDA expands use of GSK’s Blujepa as treatment for gonorrhea

US FDA expands use of GSK's Blujepa as treatment for gonorrhea The U.S. Food and Drug Administration said on Thursday it has expanded the use...

WHO chief still hopes Trump administration will rethink withdrawal

WHO chief still hopes Trump administration will rethink withdrawal The World Health Organization chief said on Thursday that he was still hoping the U.S. administration...